Selenium supplementation suppresses tumor necrosis factor α-induced human immunodeficiency virus type 1 replication in vitro

AIDS Research and Human Retroviruses

Volumn 13, Issue 15, 1997, Pages 1325-1332

  Hori, K ^a   Hatfield, D ^a   Maldarelli, F ^a   Lee, B J ^a   Clouse, K A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; SELENIUM; SELENOAMINO ACID; SELENOCYSTEINE; THIOREDOXIN REDUCTASE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADJUVANT THERAPY; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; SELENIUM DEFICIENCY; SUPPLEMENTATION; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030714995     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1325     Document Type: Article

References (56)